Innophos Holdings Inc. (NASDAQ:IPHS)’s share price shot up 2.2% during trading on Thursday . The company traded as high as $42.88 and last traded at $42.76, with a volume of 57,022 shares. The stock had previously closed at $41.84.

Separately, Zacks Investment Research raised shares of Innophos Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, May 3rd.

The company has a 50-day moving average price of $42.17 and a 200 day moving average price of $36.55. The firm has a market capitalization of $816.59 million and a P/E ratio of 32.55.

Innophos Holdings (NASDAQ:IPHS) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $0.63 EPS for the quarter, beating the Zacks’ consensus estimate of $0.57 by $0.06. The business earned $181.90 million during the quarter, compared to analyst estimates of $199.70 million. During the same quarter in the previous year, the company posted $0.65 EPS. The firm’s revenue was down 16.3% on a year-over-year basis. On average, analysts forecast that Innophos Holdings Inc. will post $2.44 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 2nd. Shareholders of record on Friday, August 19th will be issued a $0.48 dividend. The ex-dividend date of this dividend is Wednesday, August 17th. This represents a $1.92 dividend on an annualized basis and a yield of 4.52%.

In other news, VP Joseph Golowski sold 5,000 shares of the stock in a transaction that occurred on Wednesday, June 22nd. The shares were sold at an average price of $40.46, for a total value of $202,300.00. Following the completion of the sale, the vice president now owns 28,069 shares of the company’s stock, valued at approximately $1,135,671.74. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. Its segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and GTSP & Other.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.